Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of corticotropin-releasing factor receptor 1 at high agonist concentrations

Molecular Endocrinology

Volumn 26, Issue 4, 2012, Pages 681-695

  Hasdemir, Burcu ^a   Mahajan, Shilpi ^a   Bunnett, Nigel W ^a,b   Liao, Min ^a   Bhargava, Aditi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BETA ARRESTIN; CALCIUM ION; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 AGONIST; ENDOTHELIN CONVERTING ENZYME; RAB PROTEIN; RAB11 PROTEIN; RAB4 PROTEIN; UNCLASSIFIED DRUG; UROCORTIN I;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RECEPTOR BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ARRESTINS; ASPARTIC ACID ENDOPEPTIDASES; CORTICOTROPIN-RELEASING HORMONE; ENDOSOMES; HEK293 CELLS; HUMANS; MALE; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; PROTEOLYSIS; RAB GTP-BINDING PROTEINS; RAB4 GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SECOND MESSENGER SYSTEMS; SULFONAMIDES; SULFONYLUREA COMPOUNDS; TRANSPORT VESICLES; UROCORTINS;

EID: 84859146339     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1361     Document Type: Article

References (53)

1. Rivier C, Vale W 1983 Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305:325-327
2. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF 1998 Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093-1102
3. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF 2000 Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414
4. Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, Marchuk Y, Koob GF, Heinemann SF, Vale W, Lee KF 2002 Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 31:363-369
5. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, et al 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292
6. Pal K, Swaminathan K, Xu HE, Pioszak AA 2010 Structural basis for hormone recognition by the Human CRFR2α G protein-coupled receptor. J Biol Chem 285:40351-40361
7. Seachrist JL, Ferguson SS 2003 Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74: 225-235
8. Sipe DM, Murphy RF 1987 High-resolution kinetics of transferrin acidification in BALB/c 3T3 cells: exposure to pH 6 followed by temperature-sensitive alkalinization during recycling. Proc Natl Acad Sci USA 84:7119-7123
9. Yamashiro DJ, Tycko B, Fluss SR, Maxfield FR 1984 Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37:789-800
10. Padilla BE, Cottrell GS, Roosterman D, Pikios S, Muller L, Steinhoff M, Bunnett NW 2007 Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and β-arrestins. J Cell Biol 179:981-997
11. Roosterman D, Cottrell GS, Padilla BE, Muller L, Eckman CB, Bunnett NW, Steinhoff M 2007 Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling. Proc Natl Acad Sci USA 104:11838-11843
12. Cottrell GS, Padilla BE, Amadesi S, Poole DP, Murphy JE, Hardt M, Roosterman D, Steinhoff M, Bunnett NW 2009 Endosomal endothelin-converting enzyme-1: a regulator of β-arrestin-dependent ERK signaling. J Biol Chem 284:22411-22425
13. Roosterman D, Cottrell GS, Schmidlin F, Steinhoff M, Bunnett NW 2004 Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases. J Biol Chem 279:30670-30679
14. Shenoy SK, Lefkowitz RJ 2003 Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-515
15. Markovic D, Papadopoulou N, Teli T, Randeva H, Levine MA, Hillhouse EW, Grammatopoulos DK 2006 Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. J Pharmacol Exp Ther 319:1032-1042
16. Perry SJ, Junger S, Kohout TA, Hoare SR, Struthers RS, Grigoriadis DE, Maki RA 2005 Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated. J Biol Chem 280: 11560-11568
17. Oakley RH, Olivares-Reyes JA, Hudson CC, Flores-Vega F, Dautzenberg FM, Hauger RL 2007 Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and β-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses. Am J Physiol Regul Integr Comp Physiol 293:R209-R222
18. Rasmussen TN, Novak I, Nielsen SM 2004 Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of β-arrestin 1 recruitment. Eur J Biochem 271:4366-4374
19. Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE 2005 Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 26:457-470
20. Teli T, Markovic D, Levine MA, Hillhouse EW, Grammatopoulos DK 2005 Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol 19:474-490
21. Grammatopoulos DK, Randeva HS, Levine MA, Kanellopoulou KA, Hillhouse EW 2001 Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple Gproteins. J Neurochem 76:509-519
22. Hillhouse EW, Grammatopoulos DK 2006 The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27:260-286
23. Papadopoulou N, Chen J, Randeva HS, Levine MA, Hillhouse EW, Grammatopoulos DK 2004 Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1α receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol 18:624-639
24. Gutknecht E, Van der Linden I, Van Kolen K, Verhoeven KF, Vauquelin G, Dautzenberg FM 2009 Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. Mol Pharmacol 75:648-657
25. Grammatopoulos DK, Randeva HS, Levine MA, Katsanou ES, Hillhouse EW 2000 Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1α and R2β CRH receptor subtypes and stimulation of Gq-proteins. Mol Endocrinol 14:2076-2091
26. Brar BK, Chen A, Perrin MH, Vale W 2004 Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides. Endocrinology 145:1718-1729
27. Punn A, Levine MA, Grammatopoulos DK 2006 Identification of signaling molecules mediating corticotropin-releasing hormone-R1α-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol Endocrinol 20:3179-3195
28. Hemley CF, McCluskey A, Keller PA 2007 Corticotropin releasing hormone-a GPCR drug target. Curr Drug Targets 8:105-115
29. Stenmark H, Parton RG, Steele-Mortimer O, Lütcke A, Gruenberg J, Zerial M 1994 Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 13:1287-1296
30. Hasdemir B, Bunnett NW, Cottrell GS 2007 Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor. J Biol Chem 282:29646-29657
31. Cottrell GS, Padilla B, Pikios S, Roosterman D, Steinhoff M, Grady EF, Bunnett NW 2007 Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 282:12260-12271
32. Sönnichsen B, De Renzis S, Nielsen E, Rietdorf J, Zerial M 2000 Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149:901-914
33. Johnson GD, Stevenson T, Ahn K 1999 Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. J Biol Chem 274:4053-4058
34. Korth P, Bohle RM, Corvol P, Pinet F 1999 Cellular distribution of endothelin-converting enzyme-1 in human tissues. J Histochem Cytochem 47:447-462
35. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H 2000 Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21:1799-1809
36. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A 2003 Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 88:478-483
37. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H 2001 Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 86:4344-4352
38. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ 2010 Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15:877, 896-904
39. Ferguson SS, Downey III WE, Colapietro AM, Barak LS, Ménard L, Caron MG 1996 Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-366
40. Chang J, Adams MR, Clifton MS, Liao M, Brooks JH, Hasdemir B, Bhargava A 2011 Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol 300:G884-G894
41. Gourcerol G, Wu SV, Yuan PQ, Pham H, Miampamba M, Larauche M, Sanders P, Amano T, Polak A, Im E, Pothoulakis C, Rivier J, Tache Y, Million M 2011 Activation of corticotropinreleasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents. Gastroenterology 140:1586-1596
42. Larauche M, Kiank C, Tache Y 2009 Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J Physiol Pharmacol 60(Suppl 7):33-46
43. Wlk M, Wang CC, Venihaki M, Liu J, Zhao D, Anton PM, Mykoniatis A, Pan A, Zacks J, Karalis K, Pothoulakis C 2002 Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 123:505-515
44. la Fleur SE, Wick EC, Idumalla PS, Grady EF, Bhargava A 2005 Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci USA 102:7647-7652
45. Chang J, Hoy JJ, Idumalla PS, Clifton MS, Pecoraro NC, Bhargava A 2007 Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 28:1453-1460
46. Holmes KD, Babwah AV, Dale LB, Poulter MO, Ferguson SS 2006 Differential regulation of corticotropin releasing factor 1α receptor endocytosis and trafficking by β-arrestins and Rab GTPases. J Neurochem 96:934-949
47. Esseltine JL, Dale LB, Ferguson SS 2011 Rab GTPases bind at a common site within the angiotensin II type I receptor carboxylterminal tail: evidence that Rab4 regulates receptor phosphorylation, desensitization, and resensitization. Mol Pharmacol 79:175-184
48. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H 2002 Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340-346
49. Bhargava A, Dallman MF, Pearce D, Choi S 2004 Long doublestranded RNA-mediated RNA interference as a tool to achieve sitespecific silencing of hypothalamic neuropeptides. Brain Res Brain Res Protoc 13:115-125
50. Dautzenberg FM, Higelin J, Teichert U 2000 Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. Eur J Pharmacol 390:51-59
51. Cottrell GS, Padilla B, Pikios S, Roosterman D, Steinhoff M, Gehringer D, Grady EF, Bunnett NW 2006 Ubiquitin-dependent downregulation of the neurokinin-1 receptor. J Biol Chem 281:27773-27783
52. Hasdemir B, Murphy JE, Cottrell GS, Bunnett NW 2009 Endosomal deubiquitinating enzymes control ubiquitination and downregulation of protease-activated receptor 2. J Biol Chem 284: 28453-28466
53. Markovic D, Punn A, Lehnert H, Grammatopoulos DK 2008 Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2β endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol Endocrinol 22:689-706